GINKGO BIOWORKS HOLDINGS, INC. Deferred Revenue
GINKGO BIOWORKS HOLDINGS, INC. (DNA) had Deferred Revenue of $42.76 million as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2023-11-08
- 2023-09-30: Deferred Revenue, Current $42.76M.
- 2023-06-30: Deferred Revenue, Current $39.22M.
- 2023-03-31: Deferred Revenue, Current $47.52M.
- 2022-12-31: Deferred Revenue, Current $47.82M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2023-09-30 | $42.76M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $39.22M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $47.52M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $47.82M 10-Q · filed 2023-11-08 |
| 2022-09-30 | $40.51M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $45.50M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $35.23M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $33.24M 10-K · filed 2023-03-13 |
| 2021-09-30 | $29.65M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $28.82M 10-K · filed 2022-03-29 |
| 2019-12-31 | $21.82M 8-K · filed 2021-11-24 |